Excessive alcohol use (EAU) is becoming recognized as an emerging health-related problem especially among veterans returning from combats. There is a need for increased vigilance and action to identify and counsel these at-risk veterans. Unfortunately, we lack the reliable diagnostic tests to detect the dangerous levels of drinking. Such tests would be indispensable for screening and care for veterans with excessive alcohol use. We hypothesize that several novel serum and urine markers based on the effect of alcohol on immune cells can be used as the predictive biomarkers for EAU. To test this hypothesis, we plan to pursue the following specific aims.
SPECIFIC AIM # 1. To determine the effect of EAU on organ systems using system biology and by detecting, identifying, and comparing the relative quantity of these novel targets and evaluate these as potential biomarkers and SPECIFIC AIM # 2. To determine the predictive capacity of these biomarkers for alcohol-related health consequences. If successful, the results from this project will revolutionize the screening methods for veterans with excessive alcohol use.
Excessive alcohol use (EAU) is becoming recognized as an emerging health-related problem especially among veterans returning from combats. Based on the results from our previous VA merit review funding, we found that several novel serum and urine markers based on the effect of alcohol on specific cell types can be used as the predictive biomarkers for EAU. We propose to systematically study these markers as the predictive of EAU and the quantity of recent alcohol consumption. Further, we will determine the predictive capacity of these markers for alcohol-related health consequences.
|Yang, Zhihong; Ross, Ruth A; Zhao, Shi et al. (2017) LncRNA AK054921 and AK128652 are potential serum biomarkers and predictors of patient survival with alcoholic cirrhosis. Hepatol Commun 1:513-523|
|Jinjuvadia, Raxitkumar; Antaki, Fadi; Lohia, Prateek et al. (2017) The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population. J Clin Gastroenterol 51:160-166|
|Jinjuvadia, Chetna; Jinjuvadia, Raxitkumar; Mandapakala, Chaitanya et al. (2017) Trends in Outcomes, Financial Burden, and Mortality for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) in the United States from 2002 to 2010. COPD 14:72-79|
|Peng, Jennifer L; Patel, Milan Prakash; McGee, Breann et al. (2017) Management of alcohol misuse in patients with liver diseases. J Investig Med 65:673-680|
|Li, Man; He, Yong; Zhou, Zhou et al. (2017) MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47phox-oxidative stress pathway in neutrophils. Gut 66:705-715|
|Shen, Huafeng; Peng, Jennifer L; Tayarachakul, Sucharat et al. (2017) Association between serum cotinine level and prevalence of non-alcoholic fatty liver disease: a cross-sectional study from the Third National Health and Nutrition Examination Survey. J Investig Med 65:43-48|
|Liangpunsakul, Suthat; Toh, Evelyn; Ross, Ruth A et al. (2017) Quantity of alcohol drinking positively correlates with serum levels of endotoxin and markers of monocyte activation. Sci Rep 7:4462|
|Liangpunsakul, Suthat; Haber, Paul; McCaughan, Geoffrey W (2016) Alcoholic Liver Disease in Asia, Europe, and North America. Gastroenterology 150:1786-97|
|Tu, Wanzhu; Chu, Chenghao; Li, Shanshan et al. (2016) Development and validation of a composite score for excessive alcohol use screening. J Investig Med 64:1006-11|
|Shen, Huafeng; Liangpunsakul, Suthat (2016) Histamine H2-Receptor Antagonist Use Is Associated With Lower Prevalence of Nonalcoholic Fatty Liver Disease: A Population-based Study From the National Health and Nutrition Examination Survey, 2001-2006. J Clin Gastroenterol 50:596-601|
Showing the most recent 10 out of 24 publications